Evaluation of affordability and impoverishment effect of cardiovascular medicines in Iran

Q4 Pharmacology, Toxicology and Pharmaceutics Iranian Journal of Pharmaceutical Sciences Pub Date : 2018-04-01 DOI:10.22034/IJPS.2018.33739
A. Farahani, H. Rasekh, S. Najafi, Farimah Rahimi, M. Akbari, Faegheh Salehnia, Homan Hemati, Fatemeh Jajali
{"title":"Evaluation of affordability and impoverishment effect of cardiovascular medicines in Iran","authors":"A. Farahani, H. Rasekh, S. Najafi, Farimah Rahimi, M. Akbari, Faegheh Salehnia, Homan Hemati, Fatemeh Jajali","doi":"10.22034/IJPS.2018.33739","DOIUrl":null,"url":null,"abstract":"Cardiovascular disease is one of the most important causes of death in the world. There are variety of plans and strategies to treatment and prevention of CVD. Medicines have significant role to reach the goals. Ensuring Affordability of medicines is very crucial to success in these programs. The impoverishment method which focuses on the impoverishing effect of the purchasing of medicines is one the most popular methods to quantifying affordability of medicines. We applied this method to measure affordability of cardiovascular medicines in Iran. We used two poverty lines 1.25 USD and 2 USD per day which are recommended by World Bank to access the affordability of medicines. Mono therapy with one anti platelet, beta blocker, ACE inhibitor and statin as well as combination therapy have been determined. Our study highlighted that the poorest households in Iran would be at risk of pushing under poverty line because of price of the medicines.","PeriodicalId":14582,"journal":{"name":"Iranian Journal of Pharmaceutical Sciences","volume":"14 1","pages":"65-74"},"PeriodicalIF":0.0000,"publicationDate":"2018-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22034/IJPS.2018.33739","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 3

Abstract

Cardiovascular disease is one of the most important causes of death in the world. There are variety of plans and strategies to treatment and prevention of CVD. Medicines have significant role to reach the goals. Ensuring Affordability of medicines is very crucial to success in these programs. The impoverishment method which focuses on the impoverishing effect of the purchasing of medicines is one the most popular methods to quantifying affordability of medicines. We applied this method to measure affordability of cardiovascular medicines in Iran. We used two poverty lines 1.25 USD and 2 USD per day which are recommended by World Bank to access the affordability of medicines. Mono therapy with one anti platelet, beta blocker, ACE inhibitor and statin as well as combination therapy have been determined. Our study highlighted that the poorest households in Iran would be at risk of pushing under poverty line because of price of the medicines.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
评价伊朗心血管药物的可负担性和贫困化效果
心血管疾病是世界上最重要的死亡原因之一。治疗和预防心血管疾病的计划和策略多种多样。药物在实现这些目标方面发挥着重要作用。确保药品的可负担性对这些规划的成功至关重要。贫困化法侧重于药品购买的贫困化效果,是量化药品可负担性的最常用方法之一。我们应用这种方法来衡量伊朗心血管药物的可负担性。我们使用了世界银行推荐的每日1.25美元和2美元两条贫困线,以实现药品的可负担性。抗血小板,受体阻滞剂,ACE抑制剂和他汀类药物的单一治疗以及联合治疗已经确定。我们的研究强调,由于药品的价格,伊朗最贫穷的家庭将面临推至贫困线以下的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Iranian Journal of Pharmaceutical Sciences
Iranian Journal of Pharmaceutical Sciences Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
0.50
自引率
0.00%
发文量
0
期刊介绍: Iranian Journal of Pharmaceutical Sciences (IJPS) is an open access, internationally peer-reviewed journal that seeks to publish research articles in different pharmaceutical sciences subdivisions: pharmacology and toxicology, nanotechnology, pharmaceutics, natural products, biotechnology, pharmaceutical chemistry, clinical pharmacy and other pharmacy related topics. Each issue of the journal contents 16 outstanding research articles in area of pharmaceutical sciences plus an editorial written by the IJPS editors on one of the most up to date advances topics in pharmacy. All articles published by IJPS would be permanently accessible online freely without any subscription charges. Authors of the published articles have granted the right to use and disseminate their article to third parties.
期刊最新文献
Cytotoxic effect of Tilia dasystyla and Polygonatum orientale Desf extracts on AGS and SKOV-3 cancer cell lines Antibacterial Properties and Flavonoids Content of Some Mosses Common in Armenia Formulation, characterization and evaluation to establish the bioavailability of gastroretentive mucoadhesive dosage of atenolol in human subjects with possible in-vitro-in-vivo correlation Persicoimidate isolated from Allium ampeloprasum Subsp. Persicum with Apoptotic effects against Breast cancer cell lines Information Sharing and Information Quality in the Drugs and Medical Consumables Supply Chain Management (SCM)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1